Michael York - Net Worth and Insider Trading
Michael York Net Worth
The estimated net worth of Michael York is at least $145 dollars as of 2024-07-05. Michael York is the Chief Business Officer of Metacrine Inc and owns about 103,499 shares of Metacrine Inc (MTCR) stock worth over $145. Michael York is also the VP, Corporate Development of PhaseBio Pharmaceuticals Inc and owns about 1,500 shares of PhaseBio Pharmaceuticals Inc (PHASQ) stock worth over $0. Details can be seen in Michael York's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael York has not made any transactions after 2023-01-26 and currently still holds the listed stock(s).
Transaction Summary of Michael York
Michael York Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael York owns 2 companies in total, including PhaseBio Pharmaceuticals Inc (PHASQ) , and Metacrine Inc (MTCR) .
Click here to see the complete history of Michael York’s form 4 insider trades.
Insider Ownership Summary of Michael York
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PHASQ | PhaseBio Pharmaceuticals Inc | 2020-02-12 | VP & Corporate Development |
| MTCR | Metacrine Inc | 2023-01-26 | Chief Business Officer |
Michael York Latest Holdings Summary
Michael York currently owns a total of 2 stocks. Among these stocks, Michael York owns 103,499 shares of Metacrine Inc (MTCR) as of January 26, 2023, with a value of $145 and a weighting of 99.9%. Michael York also owns 1,500 shares of PhaseBio Pharmaceuticals Inc (PHASQ) as of December 11, 2018, with a value of $0 and a weighting of 0.1%.
Latest Holdings of Michael York
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MTCR | Metacrine Inc | 2023-01-26 | 103,499 | 0.00 | 145 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 2018-12-11 | 1,500 | 0.00 | 0 |
Holding Weightings of Michael York
Michael York Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael York has made a total of 1 transactions in Metacrine Inc (MTCR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Metacrine Inc is the sale of 107,054 shares on January 26, 2023, which brought Michael York around $43,892.
According to the SEC Form 4 filings, Michael York has made a total of 0 transactions in PhaseBio Pharmaceuticals Inc (PHASQ) over the past 5 years. The most-recent trade in PhaseBio Pharmaceuticals Inc is the acquisition of 1,500 shares on December 11, 2018, which cost Michael York around $5,820.
Insider Trading History of Michael York
- 1
Michael York Trading Performance
GuruFocus tracks the stock performance after each of Michael York's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael York is -24.87%. GuruFocus also compares Michael York's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael York within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael York's insider trading performs compared to the benchmark.
Performance of Michael York
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.85 | | | | | |
| Relative Return to S&P 500(%) | -1.31 | | | | | |
Michael York Ownership Network
Michael York Owned Company Details
What does PhaseBio Pharmaceuticals Inc do?
Who are the key executives at PhaseBio Pharmaceuticals Inc?
Michael York is the VP & Corporate Development of PhaseBio Pharmaceuticals Inc. Other key executives at PhaseBio Pharmaceuticals Inc include 10 percent owner New Enterprise Associates 13 Lp , VP & Human Resources Glen Burkhardt , and Chief Commercial Officer Jonathan Birchall .
PhaseBio Pharmaceuticals Inc (PHASQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PhaseBio Pharmaceuticals Inc (PHASQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
PhaseBio Pharmaceuticals Inc Insider Transactions
Michael York Mailing Address
Above is the net worth, insider trading, and ownership report for Michael York. You might contact Michael York via mailing address: C/o Phasebio Pharmaceuticals, Inc., 1 Great Valley Pkwy., Suite 30, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
